By Professor Monica M. Lahra

Book Chapters

George CRR; Jeffery HE; Lahra MM, 2022, 'Infection of mother and baby', in Keeling's Fetal and Neonatal Pathology, pp. 207 - 245, http://dx.doi.org/10.1007/978-3-030-84168-3_9

George CRR; Smith HV; Lahra MM, 2022, 'Neisseria meningitidis', in Molecular Typing in Bacterial Infections, Volume I: Second Edition, pp. 85 - 99, http://dx.doi.org/10.1007/978-3-030-74018-4_3

Goire N; Speers DJ; Lahra MM; Whiley DM, 2016, 'Neisseria gonorrhoeae: The Pathogen, Diagnosis, and Antimicrobial Resistance', in Singh SK (ed.), HUMAN EMERGING AND RE-EMERGING INFECTIONS: VIRAL AND PARASITIC INFECTIONS, VOL 1, JOHN WILEY & SONS INC, pp. 683 - 697, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000470861900038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

George CRR; Lahra MM; Jeffery HE, 2015, 'The impact of infection during pregnancy on the mother and baby', in Keeling's Fetal and Neonatal Pathology, pp. 219 - 256, http://dx.doi.org/10.1007/978-3-319-19207-9_9

Jeffery HE; Lahra MM, 2007, 'The Impact of Infection During Pregnancy on the Mother and Baby', in Fetal and Neonatal Pathology, Springer London, pp. 379 - 423, http://dx.doi.org/10.1007/978-1-84628-743-5_16

Journal articles

van Hal SJ; Le T; Jenkins F; Kundu RL; Limnios EA; McNamara LA; Sharma S; Kersh EN; Lahra MM, 2025, 'Neisseria meningitidis Serogroup Y Sequence Type 1466 and Urogenital Infections', Emerging Infectious Diseases, 31, pp. 86 - 93, http://dx.doi.org/10.3201/eid3101.240940

Lahra MM; Hutabarat SN; Hogan TR, 2024, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2024', Communicable diseases intelligence (2018), 48, http://dx.doi.org/10.33321/cdi.2024.48.54

Lahra MM; Hutabarat SN; Hogan TR, 2024, 'Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2024', Communicable diseases intelligence (2018), 48, http://dx.doi.org/10.33321/cdi.2024.48.53

Bertagnolio S; Dobreva Z; Centner CM; Olaru ID; Donà D; Burzo S; Huttner BD; Chaillon A; Gebreselassie N; Wi T; Hasso-Agopsowicz M; Allegranzi B; Sati H; Ivanovska V; Kothari KU; Balkhy HH; Cassini A; Hamers RL; Weezenbeek KV; Aanensen D; Alanio A; Alastruey-Izquierdo A; Alemayehu T; Al-Hasan M; Allegaert K; Al-Maani AS; Al-Salman J; Alshukairi AN; Amir A; Applegate T; Araj GF; Villalobos MA; Årdal C; Ashiru-Oredope D; Ashley EA; Babin FX; Bachmann LH; Bachmann T; Baker KS; Balasegaram M; Bamford C; Baquero F; Barcelona LI; Bassat Q; Bassetti M; Basu S; Beardsley J; Vásquez GB; Berkley JA; Bhatnagar AK; Bielicki J; Bines J; Bongomin F; Bonomo RA; Bradley JS; Bradshaw C; Brett A; Brink A; Brown C; Brown J; Buising K; Carson C; Carvalho AC; Castagnola E; Cavaleri M; Cecchini M; Chabala C; Chaisson RE; Chakrabarti A; Chandler C; Chandy SJ; Charani E; Chen L; Chiara F; Chowdhary A; Chua A; Chuki P; Chun DR; Churchyard G; Cirillo D; Clack L; Coffin SE; Cohn J; Cole M; Conly J; Cooper B; Corso A; Cosgrove SE; Cox H; Daley CL; Darboe S; Darton T; Davies G; de Egea V; Dedeić-Ljubović A; Deeves M; Denkinger C; Dillon JAR; Dramowski A; Eley B, 2024, 'WHO global research priorities for antimicrobial resistance in human health', The Lancet Microbe, 5, http://dx.doi.org/10.1016/S2666-5247(24)00134-4

van Hal SJ; Sherry N; Coombs G; Mowlaboccus S; Whiley DM; Lahra MM, 2024, 'Emergence of an extensively drug-resistant Neisseria gonorrhoeae clone', The Lancet Infectious Diseases, 24, pp. e547 - e548, http://dx.doi.org/10.1016/S1473-3099(24)00486-9

Unemo M; Sánchez-Busó L; Golparian D; Jacobsson S; Shimuta K; Lan PT; Eyre DW; Cole M; Maatouk I; Wi T; Lahra MM, 2024, 'The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains-phenotypic, genetic and reference genome characterization', Journal of Antimicrobial Chemotherapy, 79, pp. 1885 - 1899, http://dx.doi.org/10.1093/jac/dkae176

Lahra MM; George RCR; van Hal SJ, 2024, 'Global, regional and local surveillance of antimicrobial resistance in Neisseria gonorrhoeae', Microbiology Australia, 45, pp. 138 - 141, http://dx.doi.org/10.1071/MA24038

Lan PT; Nguyen HT; Golparian D; Thuy Van NT; Maatouk I; Unemo M; Doanh LH; Hoa PQ; Hoa PD; Minh Phuong PT; Trang TM; Dieu Van TT; Nam PT; Ha Vinh NT; Ha Giang QT; Tung VT; Tuan ND; Phan Nguyen TT; Phuong Vu TT; Thanh Nguyen PT; Duong BH; Van Loi Doan E; Thuy Nguyen DT; Le KT; Bui TM; Pham NN; Kieu Nguyen TT; Thanh Phan TT; Quynh Dang AD; Khoa NT; Lahra M; McDonald R; Kreisel K; Wi T; Schröder D; Jacobsson S, 2024, 'The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) identifies high levels of ceftriaxone resistance across Vietnam, 2023', The Lancet Regional Health - Western Pacific, 48, http://dx.doi.org/10.1016/j.lanwpc.2024.101125

Ouk V; Say HL; Virak M; Deng S; Frankson R; McDonald R; Kersh EN; Wi T; Maatouk I; van Hal S; Lahra MM; Mom PK; Fensham V; Kreisel KM; Escher M; Izumi K; Nishijima T; Unemo M; Kundu RL; Ray S; Hogan TR, 2024, 'World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme, Cambodia, 2023', Emerging Infectious Diseases, 30, pp. 1493 - 1495, http://dx.doi.org/10.3201/eid3007.240354

Sotheran E; Lane CR; Horan K; Stevens K; Guglielmino C; Bradbury S; Kennedy K; Cooley L; McEwan B; Kahler CM; Mowlaboccus S; Speers DJ; Baird R; Freeman K; Leong L; Warner M; Williamson DA; McVernon J; Lahra M; Jennison AV; Howden BP; Andersson P, 2024, 'Genomic Surveillance of Invasive Meningococcal Disease During a National MenW Outbreak in Australia, 2017-2018', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae249

Lahra MM; van Hal S; Hogan TR, 2024, 'Australian Gonococcal Surveillance Programme, 1 October to 31 December 2023', Communicable diseases intelligence (2018), 48

Lahra MM; Krishnan PS; Hogan TR, 2024, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2023', Communicable diseases intelligence (2018), 48

Lahra MM; Krishnan PS, 2024, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2023', Communicable Diseases Intelligence, http://dx.doi.org/10.33321/cdi.2024.48.21

Lahra MM; Hogan TR, 2024, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2023', Communicable diseases intelligence (2018), 48

Lahra MM; Hogan TR, 2024, 'Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2023', Communicable diseases intelligence (2018), 48

Marshall H; Ward J; Wang B; Andraweera P; McMillan M; Flood L; Bell C; Sisnowski J; Krause V; Webby R; Childs E; Gunathilake M; Egoroff N; Leong L; Lawrence A; Baird R; Freeman K; Menouhos D; Whiley DM; Karnon J; Van Hal S; Lahra MM, 2024, 'Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocol', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-079144

O’grady K; Hong S; Putsathit P; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Levy A; Moore CV; Nimmo G; Prendergast L; Robson J; Speers DJ; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR, 2024, 'Defining the phylogenetics and resistome of the major Clostridioides difficile ribotypes circulating in Australia', Microbial Genomics, 10, http://dx.doi.org/10.1099/mgen.0.001232

Seib KL; Donovan B; Thng C; Lewis DA; McNulty A; Fairley CK; Yeung B; Jin F; Fraser D; Bavinton BR; Law M; Chen MY; Chow EPF; Whiley DM; Mackie B; Jennings MP; Jennison AV; Lahra MM; Grulich AE, 2024, 'Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae infection in men who have sex with men: the GoGoVax study protocol', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-081675

Lahra MM; Latham NH; Templeton DJ; Read P; Carmody C; Ryder N; Ellis SE; Madden EF; Parasuraman A; Wells J; Sheppeard V; Armstrong BH; Holland J; Pendle S; Sherry N; Leong L; Papanicolas L; Selvey CE; Van Hal SJ, 2024, 'Investigation and response to an outbreak of Neisseria meningitidis serogroup Y ST-1466 urogenital infections, Australia', Communicable diseases intelligence (2018), 48, http://dx.doi.org/10.33321/cdi.2024.48.20

Ouk V; Heng LS; Virak M; Deng S; Lahra MM; Frankson R; Kreisel K; McDonald R; Escher M; Unemo M; Wi T; Maatouk I; Mom PK; Fensham V; Kersh E; Cavailler P; Mundade Y; van Hal SJ; Kundu RL; Hogan TR; Whiley DM; Izumi K; Nishijima T, 2024, 'High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022-23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)', JAC-Antimicrobial Resistance, 6, http://dx.doi.org/10.1093/jacamr/dlae053

O'Brien A; Hart J; Higgins A; Arthur I; Lee GH; Leung M; Kennedy K; Bradbury S; Foster S; Warren S; Korman TM; Abbott IJ; Heney C; Bletchley C; Warner M; Wells N; Wilson D; Varadhan H; Stevens R; Lahra M; Newton P; Maley M; van Hal S; Ingram PR, 2024, 'Nocardia species distribution and antimicrobial susceptibility within Australia', Internal Medicine Journal, 54, pp. 613 - 619, http://dx.doi.org/10.1111/imj.16234

Lahra MM; Van Hal S; Hogan TR, 2024, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2023', Communicable diseases intelligence (2018), 48, http://dx.doi.org/10.33321/cdi.2024.48.13

Lahra MM; Van Hal S; Hogan TR, 2024, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2023', Communicable diseases intelligence (2018), 48, http://dx.doi.org/10.33321/cdi.2024.48.12

Lahra MM; Van Hal S; Hogan TR, 2024, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2023', Communicable diseases intelligence (2018), 48, http://dx.doi.org/10.33321/cdi.2024.48.14

Lahra MM; Hogan TR, 2023, 'Meningococcal Surveillance Australia - Reporting period 1 January to 31 March 2023', Communicable diseases intelligence (2018), 47, http://dx.doi.org/10.33321/cdi.2023.47.59

Van Hal SJ; Whiley DM; Le T; Ray S; Kundu RL; Kerr E; Lahra MM, 2023, 'Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotype', Journal of Antimicrobial Chemotherapy, 78, pp. 2203 - 2208, http://dx.doi.org/10.1093/jac/dkad221

Ouk V; Pham CD; Wi T; van Hal SJ; Lahra MM, 2023, 'The Enhanced Gonococcal Surveillance Programme, Cambodia', The Lancet Infectious Diseases, 23, pp. e332 - e333, http://dx.doi.org/10.1016/S1473-3099(23)00479-6

Lahra MM; Van Hal S; Hogan TR, 2023, 'Australian Gonococcal Surveillance Programme Annual Report, 2022', Communicable diseases intelligence (2018), 47, http://dx.doi.org/10.33321/cdi.2023.47.45

Lahra MM; George CR; Van Hal S; Hogan TR, 2023, 'Australian Meningococcal Surveillance Programme Annual Report, 2022', Communicable diseases intelligence (2018), 47, http://dx.doi.org/10.33321/cdi.2023.47.44

George CRR; Lahra MM; Nguyen T; Gatus B, 2023, 'Disc Test for Detecting Staphylococcus aureus Strains Producing Type A and Type C b-Lactamases', Microbiology Spectrum, 11, http://dx.doi.org/10.1128/spectrum.00220-23

Whiley DM; Tickner JA; Kundu RL; Hogan TR; van Hal SJ; Lahra MM, 2023, 'Selection of Neisseria gonorrhoeae ceftriaxone resistance using doxycycline post-exposure prophylaxis', The Lancet Infectious Diseases, 23, pp. e268 - e269, http://dx.doi.org/10.1016/S1473-3099(23)00359-6

Bell SFE; Ware RS; Lewis DA; Lahra MM; Whiley DM, 2023, 'Antimicrobial susceptibility assays for Neisseria gonorrhoeae: a proof-of-principle population-based retrospective analysis', The Lancet Microbe, 4, pp. e544 - e551, http://dx.doi.org/10.1016/S2666-5247(23)00071-X

Lahra MM; Hurley S; Ray S; Hogan TR, 2023, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2022', COMMUNICABLE DISEASES INTELLIGENCE, 47, http://dx.doi.org/10.33321/cdi.2023.47.28

Lahra MM; Hurley SM; Ray S; Hogan TR, 2023, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2022', COMMUNICABLE DISEASES INTELLIGENCE, 47, http://dx.doi.org/10.33321/cdi.2023.47.29

Lahra MM; Hurley SM; Van Hal S; Hogan TR, 2023, 'Australian Gonococcal Surveillance Programme, 1 October to 31 December 2022', COMMUNICABLE DISEASES INTELLIGENCE, 47, http://dx.doi.org/10.33321/cdi.2023.47.30

Lahra MM; Hurley SM; Hogan TR, 2023, 'Communicable Diseases Intelligence Meningococcal Surveillance Australia Reporting period 1 October to 31 December 2022', COMMUNICABLE DISEASES INTELLIGENCE, 47, http://dx.doi.org/10.33321/cdi.2023.47.23

Lahra MM; Ray S; Hogan TR, 2023, 'Meningococcal Surveillance Australia Reporting period 1 July to 30 September 2022', Communicable diseases intelligence (2018), 47, http://dx.doi.org/10.33321/cdi.2023.47.4

Lahra MM; Ray S; Hogan TR, 2022, 'Meningococcal Surveillance Australia Reporting period 1 April to 30 June 2022', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.81

Ayfan AKS; Macdonald J; Irwin AD; Zowawi HM; Forde BM; Paterson DL; Lahra MM; Whiley DM, 2022, 'Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility', Journal of Antimicrobial Chemotherapy, 77, pp. 2933 - 2936, http://dx.doi.org/10.1093/jac/dkac242

Tickner JA; Lahra MM; Whiley DM, 2022, 'The need for a commercial test using the penA60 allele to identify ceftriaxone-resistant Neisseria gonorrhoeae', The Lancet Infectious Diseases, 22, pp. 1271 - 1272, http://dx.doi.org/10.1016/S1473-3099(22)00520-5

Lahra MM; Hogan TR; Armstrong BH, 2022, 'Australian Gonococcal Surveillance Programme Annual Report, 2021', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.52

Lahra MM; Ray S; Hogan TR, 2022, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2022', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.56

Lahra MM; Shoushtari M; Hogan TR, 2022, 'Australian Gonococcal Surveillance Programme, 1 October to 31 December 2021', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.43

Lahra MM; George CR; Hogan TR, 2022, 'Australian Meningococcal Surveillance Programme Annual Report, 2021', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.46

Lahra MM; Ray S; Hogan TR, 2022, 'Meningococcal Surveillance Australia Reporting period 1 January to 31 March 2022', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.36

Back to profile page